JILL MALINOWSKI: Open Payments
NPI 1497740542 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 29 payments from 18 companies in 2025. Trend: 2023 $349 · 2024 $735 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 6 | $98 |
| 180 Medical, Inc. | 4 | $73 |
| Myriad Genetic Laboratories, Inc. | 2 | $46 |
| TOLMAR, INC. | 2 | $44 |
| DENTSPLY IH AB | 1 | $43 |
| ABBVIE INC. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Laborie Medical Technologies Corp. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: ADSTILADRIN, GENTLECATH GLIDE, PROLARIS, JATENZO, LOFRIC, BOTOX, PLUVICTO, Nubeqa.
Industry payments across NY — which companies pay providers there.
